• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Human ovarian tissue in-vitro culture: primordial follicle activation as a new strategy for female fertility preservation.人卵巢组织体外培养:原始卵泡激活作为女性生育力保存的新策略。
Cytotechnology. 2022 Feb;74(1):1-15. doi: 10.1007/s10616-021-00510-2. Epub 2022 Jan 4.
2
Primordial follicle activation as new treatment for primary ovarian insufficiency.原始卵泡激活作为原发性卵巢功能不全的新疗法。
Clin Exp Reprod Med. 2019 Jun;46(2):43-49. doi: 10.5653/cerm.2019.46.2.43. Epub 2019 Jun 1.
3
Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency.原发性卵巢功能不全患者卵巢组织玻璃化冷冻后成功的生育力保存
Hum Reprod. 2015 Mar;30(3):608-15. doi: 10.1093/humrep/deu353. Epub 2015 Jan 6.
4
Dynamics of PI3K and Hippo signaling pathways during in vitro human follicle activation.体外人卵泡激活过程中 PI3K 和 Hippo 信号通路的动态变化。
Hum Reprod. 2018 Sep 1;33(9):1705-1714. doi: 10.1093/humrep/dey250.
5
Pharmacological inhibition of the PI3K/PTEN/Akt and mTOR signalling pathways limits follicle activation induced by ovarian cryopreservation and in vitro culture.药理学抑制 PI3K/PTEN/Akt 和 mTOR 信号通路可限制卵巢冷冻保存和体外培养诱导的卵泡激活。
J Ovarian Res. 2021 Jul 19;14(1):95. doi: 10.1186/s13048-021-00846-5.
6
Implications of Nonphysiological Ovarian Primordial Follicle Activation for Fertility Preservation.非生理性卵巢原始卵泡激活对生育力保存的影响。
Endocr Rev. 2020 Dec 1;41(6). doi: 10.1210/endrev/bnaa020.
7
Molecular Basis Associated with the Control of Primordial Follicle Activation During Transplantation of Cryopreserved Ovarian Tissue.冷冻卵巢组织移植过程中控制原始卵泡激活的分子基础。
Reprod Sci. 2021 May;28(5):1257-1266. doi: 10.1007/s43032-020-00318-z. Epub 2020 Sep 28.
8
activation of ovarian cortex and autologous transplantation: A novel approach to primary ovarian insufficiency and diminished ovarian reserve.卵巢皮质激活与自体移植:一种治疗原发性卵巢功能不全和卵巢储备功能减退的新方法。
Hum Reprod Open. 2020 Nov 16;2020(4):hoaa046. doi: 10.1093/hropen/hoaa046. eCollection 2020.
9
In-vitro regulation of primordial follicle activation: challenges for fertility preservation strategies.体外调节原始卵泡激活:生育力保存策略面临的挑战。
Reprod Biomed Online. 2018 May;36(5):491-499. doi: 10.1016/j.rbmo.2018.01.014. Epub 2018 Feb 13.
10
Spatiotemporal changes in mechanical matrisome components of the human ovary from prepuberty to menopause.人类卵巢从青春期前到绝经期机械基质组件的时空变化。
Hum Reprod. 2020 Jun 1;35(6):1391-1410. doi: 10.1093/humrep/deaa100.

引用本文的文献

1
Assessment of molecular and morphological dynamics during long-time cultivation of cryopreserved human ovarian tissue: risk of genetic alterations.冷冻保存的人卵巢组织长期培养过程中的分子和形态动力学评估:基因改变的风险
Front Endocrinol (Lausanne). 2025 May 2;15:1463614. doi: 10.3389/fendo.2024.1463614. eCollection 2024.
2
Human umbilical cord mesenchymal stem cells restore chemotherapy-induced premature ovarian failure by inhibiting ferroptosis in vitro ovarian culture system.人脐带间充质干细胞通过抑制体外卵巢培养系统中的铁死亡来恢复化疗诱导的卵巢早衰。
Reprod Biol Endocrinol. 2024 Nov 7;22(1):137. doi: 10.1186/s12958-024-01310-x.
3
Nanowarming improves survival of vitrified ovarian tissue and follicular development in a sheep model.纳米升温改善了绵羊模型中玻璃化卵巢组织的存活率和卵泡发育。
Heliyon. 2023 Aug 8;9(8):e18828. doi: 10.1016/j.heliyon.2023.e18828. eCollection 2023 Aug.

本文引用的文献

1
The effect of agar substrate on growth and development of cryopreserved-thawed human ovarian cortical follicles in organ culture.琼脂底物对人卵巢皮质卵泡冻存-解冻后在器官培养中生长和发育的影响。
Eur J Obstet Gynecol Reprod Biol. 2021 Mar;258:139-145. doi: 10.1016/j.ejogrb.2020.12.048. Epub 2020 Dec 29.
2
The combination of basic fibroblast growth factor and kit ligand promotes the proliferation, activity and steroidogenesis of granulosa cells during human ovarian cortical culture.碱性成纤维细胞生长因子和干细胞因子的联合作用可促进人卵巢皮质培养过程中颗粒细胞的增殖、活性和类固醇生成。
Cryobiology. 2020 Oct;96:30-36. doi: 10.1016/j.cryobiol.2020.08.011. Epub 2020 Aug 29.
3
Effect of sphingosine-1-phosphate on activation of dormant follicles in murine and human ovarian tissue.鞘氨醇-1-磷酸对小鼠和人类卵巢组织中休眠卵泡激活的影响。
Mol Hum Reprod. 2020 May 15;26(5):301-311. doi: 10.1093/molehr/gaaa022.
4
Drug-free in-vitro activation of follicles and fresh tissue autotransplantation as a therapeutic option in patients with primary ovarian insufficiency.在原发性卵巢功能不全患者中,作为一种治疗选择,进行无药物的体外卵泡激活和新鲜组织自体移植。
Reprod Biomed Online. 2020 Feb;40(2):254-260. doi: 10.1016/j.rbmo.2019.11.009. Epub 2019 Nov 29.
5
Rapamycin treatment maintains developmental potential of oocytes in mice and follicle reserve in human cortical fragments grafted into immune-deficient mice.雷帕霉素治疗可维持小鼠卵母细胞的发育潜能以及移植到免疫缺陷小鼠体内的人皮质碎片中的卵泡储备。
Mol Cell Endocrinol. 2020 Mar 15;504:110694. doi: 10.1016/j.mce.2019.110694. Epub 2019 Dec 27.
6
Drug-free in-vitro activation of follicles for infertility treatment in poor ovarian response patients with decreased ovarian reserve.在卵巢储备功能下降的卵巢反应不良患者中,为不孕治疗进行无药物的体外卵泡激活。
Reprod Biomed Online. 2020 Feb;40(2):245-253. doi: 10.1016/j.rbmo.2019.09.007. Epub 2019 Sep 19.
7
Biopsying, fragmentation and autotransplantation of fresh ovarian cortical tissue in infertile women with diminished ovarian reserve.对卵巢储备功能下降的不孕妇女进行新鲜卵巢皮质组织活检、分割和自体移植。
Hum Reprod. 2019 Oct 2;34(10):1924-1936. doi: 10.1093/humrep/dez152.
8
Activation Prior to Transplantation of Human Ovarian Tissue: Is It Truly Effective?人卵巢组织移植前的激活:它真的有效吗?
Front Endocrinol (Lausanne). 2019 Aug 2;10:520. doi: 10.3389/fendo.2019.00520. eCollection 2019.
9
Primordial follicle activation as new treatment for primary ovarian insufficiency.原始卵泡激活作为原发性卵巢功能不全的新疗法。
Clin Exp Reprod Med. 2019 Jun;46(2):43-49. doi: 10.5653/cerm.2019.46.2.43. Epub 2019 Jun 1.
10
Future developments: In vitro growth (IVG) of human ovarian follicles.未来的发展:人类卵巢滤泡的体外生长(IVG)。
Acta Obstet Gynecol Scand. 2019 May;98(5):653-658. doi: 10.1111/aogs.13592. Epub 2019 Apr 5.

人卵巢组织体外培养:原始卵泡激活作为女性生育力保存的新策略。

Human ovarian tissue in-vitro culture: primordial follicle activation as a new strategy for female fertility preservation.

作者信息

Ghezelayagh Zeinab, Khoshdel-Rad Niloofar, Ebrahimi Bita

机构信息

Department of Embryology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.

Department of Developmental Biology, Faculty of Basic Sciences and Advanced Technologies in Biology, University of Science and Culture, ACECR, Tehran, Iran.

出版信息

Cytotechnology. 2022 Feb;74(1):1-15. doi: 10.1007/s10616-021-00510-2. Epub 2022 Jan 4.

DOI:10.1007/s10616-021-00510-2
PMID:35185282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8816997/
Abstract

Cryopreservation and transplantation of ovarian tissue is the only fertility preservation option used for prepubertal girls and women who don't have a chance for embryo or oocyte vitrification. For women with aggressive cancer, hormone-responsive malignancies, autoimmune diseases, etc. ovary transplantation cannot be performed so an alternative technology called in-vitro follicle activation is thinkable. In this method, dormant primordial follicles are activated from the resting primordial pool by in-vitro culture and enter their growth phase. Different in-vitro culture media and supplements in addition to various culturing methods have been conducted for activating these dormant follicles. Furthermore, several signaling pathways such as Hippo, phosphatidylinositol-3-kinase, and mTOR influence follicle activation. Therefore, the addition of different activators of these signaling pathways can beneficially regulate this culture system. This review summarizes the findings on different aspects of human ovarian tissue culture strategies for in-vitro follicular activation, their medium, and different factors involved in this activation. Afterward, signaling pathways important for follicle activation and their clinical applications towards improving activation in culture are also reviewed.

摘要

卵巢组织的冷冻保存和移植是用于青春期前女孩和没有机会进行胚胎或卵母细胞玻璃化冷冻的女性的唯一生育力保存选择。对于患有侵袭性癌症、激素反应性恶性肿瘤、自身免疫性疾病等的女性,无法进行卵巢移植,因此一种名为体外卵泡激活的替代技术是可行的。在这种方法中,休眠的原始卵泡通过体外培养从静止的原始卵泡池中被激活并进入生长阶段。除了各种培养方法外,还使用了不同的体外培养基和添加剂来激活这些休眠卵泡。此外,几种信号通路,如Hippo、磷脂酰肌醇-3-激酶和mTOR,会影响卵泡激活。因此,添加这些信号通路的不同激活剂可以有益地调节这个培养系统。本综述总结了关于人类卵巢组织培养策略在体外卵泡激活的不同方面、其培养基以及参与这种激活的不同因素的研究结果。随后,还综述了对卵泡激活重要的信号通路及其在改善培养中激活方面的临床应用。